Klaria Year-End Report Q4 2021
Klaria Year-End Report Q4 2021Summary of the Year-End Report Promising quarter with registration applications and preparations for additional clinical studies Fourth quarter of 2021 - Net sales amounted to 0.0 MSEK (0.0 MSEK) - Other income amounted to 6.2 MSEK (2.0 MSEK) - R&D costs for the period amounted to 28.1 MSEK (17.6 MSEK) - Profit after tax amounted to -39.1 MSEK (-17.0 MSEK) - Earnings per share for the quarter amounted to -0.75 SEK (-0.36 SEK) - Cash flow from operating activities amounted to -14.6 MSEK (-10.0 MSEK) - Cash and cash equivalents on the